Filed: 2/13/2026ACC: 0001193125-26-051785
📋 What this filing means
TRV GP V, LLC filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $429.17M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$429.17M
Total AUM (reported)
14.30M
Total Shares
Allocation by class
COM$429.17M100.0%
Portfolio Concentration
Top 3$429.17M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 14.30M
Sole
Full voting authority
14.30M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
RAPPORT THERAPEUTICS, INC.
SOLEShares7.14M
TypeSH
Market value$216.48M
50.44%
Sole
7.14M
Shared
0.00
None
0.00
SEPTERNA, INC.
SOLEShares6.22M
TypeSH
Market value$173.29M
40.38%
Sole
6.22M
Shared
0.00
None
0.00
MAZE THERAPEUTICS, INC.
SOLEShares950.80K
TypeSH
Market value$39.39M
9.18%
Sole
950.80K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
RAPPORT THERAPEUTICS, INC.SOLE | COM | 7.14M | SH | $216.48M 50.44% | 7.14M | 0.00 | 0.00 |
SEPTERNA, INC.SOLE | COM | 6.22M | SH | $173.29M 40.38% | 6.22M | 0.00 | 0.00 |
MAZE THERAPEUTICS, INC.SOLE | COM | 950.80K | SH | $39.39M 9.18% | 950.80K | 0.00 | 0.00 |